Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 4/20 | 0.40 |
| ▸ | MAOB | P27338 | 4/20 | 0.40 |
| ▸ | ACHE | P22303 | 2/20 | 0.40 |
| ▸ | REN | P00797 | 3/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.37 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.36 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | TOP2A | P11388 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24768872 | 0.86 | KDM4E (0.44) | KDM4EATML3MBTL1ALDH1A1FGFR1 | |
| SCHEMBL13556868 | 0.81 | TNF (0.49) | KDM4EALDH1A1 | |
| SCHEMBL13866625 | 0.81 | ATM (0.56) | KDM4EATML3MBTL1ALDH1A1FGFR1 | |
| SCHEMBL2627495 | 0.81 | L3MBTL1 (0.61) | KDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL23259773 | 0.81 | MAPK1 (0.47) | L3MBTL1ALDH1A1MAOAMAOBACHE | |
| SCHEMBL24768833 | 0.80 | ATM (0.36) | KDM4EATML3MBTL1ALDH1A1MAOA | |
| SCHEMBL13556860 | 0.80 | NPC1 (0.40) | KDM4EALDH1A1MAOAMAOBACHE | |
| SCHEMBL12098614 | 0.80 | KDM4E (0.67) | KDM4EATML3MBTL1ALDH1A1FGFR1 | |
| SCHEMBL17989811 | 0.79 | L3MBTL1 (0.43) | KDM4EATML3MBTL1ALDH1A1CYP1A2 | |
| SCHEMBL18958267 | 0.79 | KDM4E (0.47) | KDM4EATML3MBTL1ALDH1A1FGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8889270-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2014-11-18 | — | — | US | disclosed |
| US-8889270-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2014-11-18 | — | — | US | disclosed |
| US-20120267613-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2012-10-25 | — | — | US | disclosed |
| US-20120267613-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2012-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120267613-A1 | ORGANIC LIGHT-EMITTING DEVICE | CRY1, CYP1A1, CRY2 | KDM4E 3048/4885ATM 1079/4885L3MBTL1 77/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.